Jul 30

Align Technology settles patent litigation with Ormco Align Technology.

Align Technology settles patent litigation with Ormco Align Technology, Inc www.med-drugs.com . Today announced that it has reached funds with Ormco Corporation , a subsidiary of Danaher Corporation, to end all pending litigation between your parties and to begin a new strategic collaboration.As part of the settlement, Align will make a cash payment of approximately $13 million to Ormco and issue approximately 7.6 million shares of Align’s Common Stock to Danaher Corporation, Ormco’s ultimate parent, that after issuance will become equal to ten % ownership benefit in Align approximately.

With other components of our integrated brand identity Together, it represents an excellent step forward in elevating Algos’ image and extending our reach to Big Pharma and the medical device manufacturing industry.’ Algos programs to officially unveil its new look at the Society for Neuroscience in Chicago from October 17-21, Booth #600.. Algos Therapeutics changes name to Algos Preclinical Services Following a shift in its business design from developing proprietary pain therapy products to natural contract study, Algos Therapeutics has changed its name to Algos Preclinical Services. The company’s new tagline, ‘Expertise in pain.